| [1] SCHWAB J M, BRECHTEL K, MUELLER C A, et al. Experimental strategies to promote spinal cord regeneration—an integrative perspective [J]. Prog Neurobiol, 2006, 78(2):91-116.
[2] YONG V W. Metalloproteinases: mediators of pathology and regeneration in the CNS [J]. Nat Rev Neurosci, 2005,6(12):931-944.
[3] HARAGUCHI M, OKUBO T, MIYASHITA Y, et al. Snail regulates cell-matrix adhesion by regulation of the expression of integrins and basement membrane proteins [J]. J Biol Chem, 2008, 283 (35):23514-23523.
[4] GAUDET A D, POPOVICH P G. Extracellular matrix regulation of inflammation in the healthy and injured spinal cord [J]. Exp Neurol, 2014, 258: 24-34.
[5] JIANG D, LIANG J, FAN J, et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan [J]. Nat Med, 2005, 11(11):1173-1179.
[6] COLLINS S L, BLACK K E, CHAN-LI Y, et al, Hyaluronan fragments promote inflammation by down-regulating the anti-inflammatory A2a receptor [J]. Am J Respir Cell Mol Biol, 2011, 45 (4):675-683.
[7] REIJERKERK A, KOOIJ G, VAN DER POL S M, et al. Diapedesis of monocytes is associated with MMP-mediated occludin disappearance in brain endothelial cells [J]. FASEB J, 2006, 20 (14):2550-2552.
[8] LU D Y, YU W H, YEH W L, et al. Hypoxia-induced matrix metalloproteinase-13 expression in astrocytes enhances permeability of brain endothelial cells [J]. J Cell Physiol, 2009, 220(1):163-173.
[9] YANG Y, ESTRADA E Y, THOMPSON J F, et al. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat [J]. J Cereb Blood Flow Metab, 2007, 27(4):697-709.
[10] VANDENBROUCKE R E, DEJONCKHEERE E, VAN HAUWERMEIREN F, et al. Matrix metalloproteinase 13 modulates intestinal epithelial barrier integrity in inflammatory diseases by activating TNF [J]. EMBO Mol Med, 2013, 5(7):932-948.
[11] NOBLE L J, DONOVAN F, IGARASHI T, et al. Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events [J]. J Neurosci, 2002, 22(17):7526-7535.
[12] VARGAS M E, BARRES B A. Why is Wallerian degeneration in the CNS so slow? [J]. Annu Rev Neurosci, 2007, 30: 153-179.
[13] CUI Q, YIN Y, BENOWITZ L I. The role of macrophages in optic nerve regeneration [J]. Neuroscience, 2009, 158(3):1039-1048.
[14] NISSINEN L, KHRI V M. Matrix metalloproteinases in inflammation [J]. Biochim Biophys Acta, 2014, 1840(8):2571-2580.
[15] VACHON P H. Integrin signaling, cell survival, and anoikis: distinctions, differences, and differentiation [J]. J Signal Transduct, 2011, 2011: 738137.
[16] YANG Y, CANDELARIO-JALIL E, THOMPSON J F, et al. Increased intranuclear matrix metalloproteinase activity in neurons interferes with oxidative DNA repair in focal cerebral ischemia [J]. J Neurochem, 2010, 112(1):134-149.
[17] GU Z, KAUL M, YAN B, et al. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death [J]. Science, 2002, 297(5584):1186-1190.
[18] WALKER E J, ROSENBERG G A. TIMP-3 and MMP-3 contribute to delayed inflammation and hippocampal neuronal death following global ischemia [J]. Exp Neurol, 2009, 216(1):122-131.
[19] HUR E M, SAIJILAFU, ZHOU F Q. Growing the growth cone: remodeling the cytoskeleton to promote axon regeneration [J]. Trends Neurosci, 2012, 35(3):164-174.
[20] OGIER C, BERNARD A, CHOLLET A M, et al. Matrix metalloproteinase-2 (MMP-2) regulates astrocyte motility in connection with the actin cytoskeleton and integrins [J]. Glia, 2006, 54(4):272-284.
[21] FURUTANI Y, MATSUNO H, KAWASAKI M, et al. Interaction between telencephalin and ERM family proteins mediates dendritic filopodia formation [J]. J Neurosci, 2007, 27(33):8866-8876.
[22] LIN K T, SLONIOWSKI S, ETHELL D W, et al. Ephrin-B2-induced cleavage of EphB2 receptor is mediated by matrix metalloproteinases to trigger cell repulsion [J]. J Biol Chem, 2008, 283(43):28969-28979.
[23] FILBIN M T. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS [J]. Nat Rev Neurosci, 2003, 4(9):703-713.
[24] PIZZI M A, CROWE M J. Matrix metalloproteinases and proteoglycans in axonal regeneration [J]. Exp Neurol, 2007, 204(2):496-511.
[25] MILWARD E, KIM K J, SZKLARCZYK A, et al. Cleavage of myelin associated glycoprotein by matrix metalloproteinases [J]. J Neuroimmunol, 2008, 193(1-2):140-148.
[26] WALMSLEY A R, MCCOMBIE G, NEUMANN U, et al. Zinc metalloproteinase-mediated cleavage of the human Nogo-66 receptor [J]. J Cell Sci, 2004, 117(Pt 19): 4591-4602.
[27] JAIN A, MCKEON R J, BRADY-KALNAY S M, et al. Sustained delivery of activated Rho GTPases and BDNF promotes axon growth in CSPG-rich regions following spinal cord injury [J]. PloS One, 2011, 6(1):e16135.
[28] DUCHOSSOY Y, HORVAT J C, STETTLER O. MMP-related gelatinase activity is strongly induced in scar tissue of injured adult spinal cord and forms pathways for ingrowing neurites [J]. Mol Cell Neurosci, 2001, 17(6):945-956.
[29] HSU J Y, MCKEON R, GOUSSEV S, et al. Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury [J]. J Neurosci, 2006, 26 (39):9841-9850.
[30] ROLLS A, AVIDAN H, CAHALON L, et al. A disaccharide derived from chondroitin sulphate proteoglycan promotes central nervous system repair in rats and mice [J]. Eur J Neurosci, 2004, 20(8):1973-1983.
[31] SAYGILI E, SCHAUERTE P, PEKASSA M, et al. Sympathetic neurons express and secrete MMP-2 and MT1 -MMP to control nerve sprouting via pro-NGF conversion [J]. Cell Mol Neurobiol, 2011, 31 (1):17-25.
[32] HWANG J J, PARK M H, CHOI S Y, et al. Activation of the Trk signaling pathway by extracellular zinc. Role of metalloproteinases [J]. J Biol Chem, 2005, 280(12):11995-12001.
[33] MONGIAT M, OTTO J, OLDERSHAW R, et al. Fibroblast growth factor-binding protein is a novel partner for perlecan protein core [J]. J Biol Chem, 2001, 276(13):10263-10271.
[34] FOWLKES J L, SERRA D M, BUNN R C, et al. Regulation of insulin-like growth factor (IGF)-I action by matrix metalloproteinase-3 involves selective disruption of IGF-I/IGF-binding protein-3 complexes [ J]. Endocrinology, 2004,145(2):620-626.
[35] SILVER J, MILLER J H. Regeneration beyond the glial scar [J]. Nat Rev Neurosci, 2004, 5(2):146-156.
[36] GOUSSEV S, HSU J Y, LIN Y, et al. Differential temporal expression of matrix metalloproteinases after spinal cord injury: relationship to revascularization and wound healing [J]. J Neurosurg,2003, 99(2 Suppl):188-197.
[37] HSU J Y, BOURGUIGNON L Y, ADAMS C M, et al. Matrix metalloproteinase-9 facilitates glial scar formation in the injured spinal cord [J]. J Neurosci, 2008, 28(50):13467-13477.
[38] PASTRANA E, MORENO-FLORES M T, GURZOV E N, et al. Genes associated with adult axon regeneration promoted by olfactory ensheathing cells: a new role for matrix metalloproteinase 2 [J]. J Neurosci, 2006, 26(20):5347-5359.
[39] VEERAVALLI K K, DASARI V R, TSUNG A J, et al. Human umbilical cord blood stem cells upregulate matrix metalloproteinase-2 in rats after spinal cord injury [J]. Neurobiol Dis, 2009, 36 (1):200-212.
[40] YANG L J, SCHNAAR R L. Axon regeneration inhibitors [J]. Neurol Res, 2008, 30 (10):1047-1052.
[41] GUEYE Y, FERHAT L, SBAI O, et al. Trafficking and secretion of matrix metalloproteinase-2 in olfactory ensheathing glial cells: A role in cell migration [J]. Glia, 2011, 59(5):750-770.
[42] PLEMEL J R, KEOUGH M B, DUNCAN G J, et al. Remyelination after spinal cord injury: is it a target for repair? [J]. Prog Neurobiol, 2014, 117: 54-72.
[43] OH L Y, LARSEN P H, KREKOSKI C A, et al. Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes [J]. J Neurosci, 1999, 19(19):8464-8475.
[44] LARSEN P H, WELLS J E, STALLCUP W B, et al. Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan [J]. J Neurosci,2003, 23(35):11127-11135.
[45] LARSEN P H, DASILVA A G, CONANT K, et al. Myelin formation during development of the CNS is delayed in matrix metalloproteinase-9 and-12 null mice [J]. J Neurosci, 2006, 26(8):2207 -2214. |
